德維特保健合作公司DVA
紐約證券 · USD
150.76
+0.82
(+0.55%)
收盤 03/07 04:59 (UTC+8)
03/07 04:59 (UTC+8)
德維特保健合作公司DVA
150.76
+0.82
(+0.55%)
財務數據
損益表
- 31.21
- 31.46
- 30.71
- 31.87
- 32.64
- 32.95
- 32.24
- 33.80
- 34.20
- 36.20
- 4.03
- 0.78
- -2.39
- 3.78
- 2.41
- 0.95
- -2.16
- 4.84
- 1.20
- 5.83
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 3,619,787 | 3,420,227 | 3,379,526 | 3,223,529 | 3,294,683 | 3,263,590 | 3,186,722 | 3,070,555 | 3,145,747 | 3,121,332 |
營業成本 | 2,409,517 | 2,332,759 | 2,261,540 | 2,239,660 | 2,225,371 | 2,151,875 | 2,142,299 | 2,078,976 | 2,138,369 | 2,067,315 |
營業毛利 | 1,210,270 | 1,087,468 | 1,117,986 | 983,869 | 1,069,312 | 1,111,715 | 1,044,423 | 991,579 | 1,007,378 | 1,054,017 |
營業費用 | 659,065 | 591,863 | 587,509 | - | 588,584 | - | - | - | 622,831 | 565,306 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 472,362 | 414,373 | 412,805 | 374,090 | 414,482 | 393,534 | 367,845 | 362,480 | 401,471 | 376,883 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 26,083 | - |
其他營業費用 | 186,703 | 177,490 | 174,704 | 176,451 | 174,102 | 187,014 | 175,661 | 187,083 | 195,277 | 188,423 |
營業利益 | 561,070 | 505,767 | 537,841 | 438,937 | 565,362 | 534,878 | 506,398 | 483,845 | 389,909 | 495,939 |
其他收入及費用 | -178,311 | -196,964 | -168,913 | -152,604 | -77,310 | -161,444 | -134,958 | -76,912 | -100,842 | -117,730 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 382,759 | 308,803 | 368,928 | 286,333 | 413,733 | 373,434 | 371,440 | 371,786 | 289,067 | 378,209 |
所得稅 | 76,728 | 68,554 | 93,708 | 54,117 | 64,488 | 77,674 | 71,688 | 65,806 | 58,495 | 68,848 |
稅後純益 | 234,217 | 150,332 | 199,337 | 162,917 | 259,329 | 214,688 | 222,676 | 239,649 | 150,665 | 246,632 |
基本每股稅後盈餘(元) | 3.36 | 2.09 | 2.62 | 2.05 | 3.18 | 2.56 | 2.56 | 2.73 | 1.67 | 2.70 |
稀釋每股稅後盈餘(元) | 3.22 | 2.05 | 2.57 | 2.00 | 3.07 | 2.51 | 2.50 | 2.65 | 1.62 | 2.63 |
基本平均股數(千股) | 69652.00 | 72075.00 | 75943.00 | 79368.00 | 81620.00 | 83721.00 | 86899.00 | 87775.00 | 90353.00 | 91322.00 |
稀釋平均股數(千股) | 71261.00 | 73769.00 | 77362.00 | 81275.00 | 83854.00 | 85795.00 | 88950.00 | 90547.00 | 92782.00 | 94041.00 |
還原基本每股稅後盈餘(元) | 3.36 | 2.09 | 2.62 | 2.05 | 3.18 | 2.56 | 2.56 | 2.73 | 1.67 | 2.70 |
還原稀釋每股稅後盈餘(元) | 3.22 | 2.05 | 2.57 | 2.00 | 3.07 | 2.51 | 2.50 | 2.65 | 1.62 | 2.63 |
還原基本平均股數(千股) | 69,652 | 72,075 | 75,943 | 79,368 | 81,620 | 83,721 | 86,899 | 87,775 | 90,353 | 91,322 |
還原稀釋平均股數(千股) | 71,261 | 73,769 | 77,362 | 81,275 | 83,854 | 85,795 | 88,950 | 90,547 | 92,782 | 94,041 |
EBITDA(千元) | 497,648 | 396,376 | 467,749 | 393,485 | 497,919 | 479,376 | 470,025 | 492,538 | 404,437 | 503,903 |